Composition for Treating Cirrhosis and Liver Cancer (SB-1121)
Status:
Completed
Trial end date:
2021-11-10
Target enrollment:
Participant gender:
Summary
The composition treats cirrhosis and hepatocellular carcinoma (Hcc) at an early stage. The
product is extracted from herbs, including Adenosma glutinosum extract, Eclipta prostrata
extract, Phyllanthus urinaria extract, Impatiens balsamina extract, Ascorbic acid, pyridoxine
5-phosphate, L-Arginine hydrochloride, Pregnenolone acetate. These components have
participated in repairing and regenerating new liver parenchyma, preventing fibrosis cell
generation, preventing liver cancer cell growth at an early stage. The composition
supplements precursors which help the body strengthen antibodies and reduce the risk of
inflammation, restore physiological and biochemical functions of liver cells after chronic
inflammation.